Australia markets closed

Boston Scientific Corporation (BSX)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
87.10+0.90 (+1.04%)
At close: 04:00PM EDT
87.45 +0.35 (+0.41%)
After hours: 07:58PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
1,828,000
1,593,000
698,000
1,041,000
-82,000
-
Depreciation & amortisation
1,228,000
1,196,000
1,136,000
1,093,000
1,123,000
-
Deferred income taxes
65,000
-1,000
-63,000
-124,000
-82,000
-
Stock-based compensation
261,000
233,000
220,000
194,000
170,000
-
Change in working capital
-1,185,000
-770,000
-1,005,000
-351,000
-23,000
-
Accounts receivable
-305,000
-238,000
-220,000
-279,000
335,000
-
Inventory
-480,000
-660,000
-321,000
-346,000
-65,000
-
Accounts payable
-339,000
118,000
-255,000
408,000
-28,000
-
Other working capital
1,686,000
1,703,000
914,000
1,316,000
1,132,000
-
Other non-cash items
93,000
136,000
191,000
-25,000
202,000
-
Net cash provided by operating activities
2,632,000
2,503,000
1,526,000
1,870,000
1,508,000
-
Cash flows from investing activities
Investments in property, plant and equipment
-946,000
-800,000
-612,000
-554,000
-376,000
-
Acquisitions, net
-888,000
-1,811,000
-1,542,000
-2,258,000
-3,000
-
Purchases of investments
-
-
-24,000
-
-146,000
-348,000
Sales/maturities of investments
0
2,000
56,000
15,000
0
-
Other investing activities
-
1,000
-
-1,000
87,000
1,000
Net cash used for investing activities
-1,806,000
-2,574,000
-2,011,000
-1,597,000
-411,000
-
Cash flows from financing activities
Debt repayment
-533,000
-4,000
-3,435,000
0
-6,843,000
-
Common stock issued
-
-
0
0
975,000
0
Common stock repurchased
-
-
0
0
-535,000
0
Dividends paid
0
-28,000
-55,000
-55,000
-28,000
-
Other financing activities
-65,000
-89,000
-411,000
-100,000
-147,000
-
Net cash used provided by (used for) financing activities
1,624,000
5,000
-547,000
-95,000
294,000
-
Net change in cash
2,442,000
-70,000
-1,042,000
173,000
1,388,000
-
Cash at beginning of period
620,000
1,126,000
2,168,000
1,995,000
607,000
-
Cash at end of period
3,071,000
1,055,000
1,126,000
2,168,000
1,995,000
-
Free cash flow
Operating cash flow
2,632,000
2,503,000
1,526,000
1,870,000
1,508,000
-
Capital expenditure
-946,000
-800,000
-612,000
-554,000
-376,000
-
Free cash flow
1,686,000
1,703,000
914,000
1,316,000
1,132,000
-